📰 Simon Ittig News

Simon Ittig News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Simon Ittig. Real-time updates on events, politics, business and more.

Boehringer Ingelheim announces acquisition of T3 Pharmaceuticals

November 24, 2023

Boehringer Ingelheim has announced the acquisition of Switzerland-based biotech company T3 Pharmaceuticals in a deal valued at up to CHF450m ($509m).

Simon Ittig Michel Pairet Boehringer Ingelheim University Of Basel Ingelheim Board Managing Directors

Source: pharmaceutical-business-review.com

Boehringer Ingelheim expands immunooncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

November 23, 2023

Boehringer Ingelheim today announced the acquisition of privatelyheld T3 Pharmaceuticals AG T3 Pharma a clinical stage Swiss biotech company for an amount of up to 450 million CHF.

Switzerland General Boehringer Ingelheim Engagers Tces Simon Ittig Michel Pairet Boehringer Ingelheim Venture Fund

Source: businesswireindia.com

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

November 23, 2023

Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF. T3 Pharma has developed a proprietary therapy platform that uses live bacteria to deliver immune-modulating proteins to cancer ...

Switzerland General Michel Pairet Simon Ittig Boehringer Ingelheim Engagers Tces University Of Basel

Source: pharmiweb.com